Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Harvard Apparatus Regenerative Technology Q3 2026 Results: Net Loss of $1.46M, Loss Narrows

For the nine months ended September 30, 2026, Harvard Apparatus Regenerative Technology reported a net loss of $4.8 million, a slight improvement from the $5.2 million loss in the prior year period. While product revenue increased to $785,000, the company continues to operate with a significant accumulated deficit of $111.3 million and highlights its dependence on future capital raises to continue as a going concern.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.10.1
Net income-1.5-1.7
EPS (diluted, $ a share)$-0.08$-0.10

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+17.9%
Source

10-Q filed with the SEC, OTC: HRGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Harvard Apparatus Regenerative Technology, Inc.: key numbers

Share price
$1.90Close, Nov 16
Market cap
$38.2M
Shares outstanding
20.09MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Harvard Apparatus Regenerative Technology, Inc.

All →
10:52 AM ET Form 4
Insider Buying

Harvard Apparatus Regenerative Technology CEO Junli He Buys $394K of Stock

Junli He, CEO, bought 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. at $1.05 to $2.15 a share (average $1.07) in 2 transactions, worth $394K in total between Sep 11, 2026 and Sep 15, 2026. Shares held after the trade: 1,332,930 (+0.5%).

Value
$394K
Shares
368,630
Average price
$1.07
Role
CEO
Holding change
+0.5%
Trade date
Sep 11, 2026 to Sep 15, 2026
10:12 AM ET 8-K
Capital Raise

Harvard Apparatus Regenerative Technology Capital Raise of $2.84M

Harvard Apparatus Regenerative Technology closed a private placement of 2,703,727 shares of common stock at $1.05 per share for total proceeds of approximately $2.84 million. The transaction included a $717,911 debt-for-equity conversion by CEO Jerry (Junli) He, who cancelled outstanding bridge promissory notes in exchange for shares at the same offering price.

Value
$2.84M
Counterparty
Jerry (Junli) He and other private investors

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.